Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
J04AC01
|
| gptkbp:brand |
gptkb:isoniazid
|
| gptkbp:CASNumber |
54-85-3
|
| gptkbp:chemicalFormula |
C6H7N3O
|
| gptkbp:contraindication |
gptkb:liver_disease
|
| gptkbp:developedBy |
antitubercular therapy
|
| gptkbp:discoveredIn |
1952
|
| gptkbp:excretion |
gptkb:kidney
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nydrazid
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits mycolic acid synthesis
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intramuscular |
| gptkbp:sideEffect |
peripheral neuropathy
hepatotoxicity |
| gptkbp:usedFor |
tuberculosis
|
| gptkbp:bfsParent |
gptkb:isoniazid
|
| gptkbp:bfsLayer |
6
|